好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

A Retrospective Analysis of Hospice and Non-hospice Patients in an Interdisciplinary Movement Disorders Supportive Care Clinic
Movement Disorders
P10 - Poster Session 10 (8:00 AM-9:00 AM)
16-004

To compare demographic characteristics, disease history, symptom burden, and advance care planning between patients in the Advanced Interdisciplinary Movement Disorders Supportive Care (AIMS) clinic who died with or without hospice involvement.

The AIMS clinic provides interdisciplinary care for patients with advanced Parkinsonism. The team includes neurology, palliative care, social work, dietetics, and nursing.

We conducted a retrospective chart review of 175 AIMS patients seen between October 2019 to December 2023. Data was collected on demographics, disease history, Edmonton Symptom Assessment Scales (ESAS), Parkinson’s Disease Questionnaires (PDQ-8), hospice referrals, mortality (if applicable), and advance care planning (Physician Orders for Life Sustaining Measures (POLST), Healthcare Power of Attorney (HCPOA)). 

18 patients died without hospice and 39 died with hospice. Median AIMS visits prior to death were 1 (IQR 1–2) for non-hospice and 2 (IQR 1–4) for hospice patients (p = 0.01). Median time from last visit to death was 9 months (IQR 5–12) without hospice versus 2 months (IQR 1–6) with hospice (p = 0.005). Completion of POLST/MOLST forms occurred in 23.1% of hospice patients and 0% without hospice (p = 0.045). HCPOA review was more frequent among hospice patients (71.8% vs 38.9%; p = 0.02). Hospice patients reported higher depression scores on the ESAS (median 5 [IQR 0–6] vs 0 [IQR 0–4]; p = 0.048) and PDQ-8 (median 1.6 [IQR 1–3] vs 0 [IQR 0–1.3]; p = 0.03).

Hospice enrollment was associated with closer clinical follow-up, greater engagement in advance care planning and higher rates depression symptoms.  These findings suggest that mood symptoms and patterns of healthcare utilization may serve as early indicators of transition and readiness for hospice, which highlights the need for proactive palliative care integration into advanced Parkinson’s management.

Authors/Disclosures
Angela A. Hong, MD (University Commons)
PRESENTER
Dr. Hong has nothing to disclose.
Mariya Husain, MD (Rush University) Dr. Husain has nothing to disclose.
Neha M. Kramer, MD (Rush University Medical Center) Dr. Kramer has nothing to disclose.
Sarah M. Chen, LCSW Ms. Chen has nothing to disclose.
Kristin h. Gustashaw, Clinical Dietitian An immediate family member of Ms. Gustashaw has received personal compensation for serving as an employee of Hormel Health Labs.
Grace Hong, RN Ms. Hong has nothing to disclose.
Bichun Ouyang Bichum Ouyang has nothing to disclose.
Sarah Kee Ms. Kee has nothing to disclose.
Deepa H. Shankar Miss Shankar has nothing to disclose.
Jori Fleisher, MD, MSCE, FAAN (Rush University Parkinson's and Movement Disorders Program) The institution of Dr. Fleisher has received research support from Parkinson's Foundation. The institution of Dr. Fleisher has received research support from NIH/NINDS. The institution of Dr. Fleisher has received research support from NIH/NINDS. The institution of Dr. Fleisher has received research support from NIA/NINDS. The institution of Dr. Fleisher has received research support from NIA/NINDS. Dr. Fleisher has received publishing royalties from a publication relating to health care. Dr. Fleisher has received personal compensation in the range of $0-$499 for serving as a Speaker with Parkinson's Foundation. Dr. Fleisher has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Lewy Body Dementia Association. Dr. Fleisher has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Davis Phinney Foundation. Dr. Fleisher has a non-compensated relationship as a Editorial Board Member with AAN Brain & Life Magazine that is relevant to AAN interests or activities.